Decreased interferon-? induced STAT-4 activation in immune cells and clinical outcome in multiple sclerosis
(2016)
Journal Article
Tanasescu, R., Midgley, A., Robins, R. A., & Constantinescu, C. S. (in press). Decreased interferon-? induced STAT-4 activation in immune cells and clinical outcome in multiple sclerosis. Acta Neurologica Scandinavica, https://doi.org/10.1111/ane.12715
Objectives. Interferon-? (IFN-?) is used in the treatment of multiple sclerosis (MS). IFN-? activation of signal transduction and activation of transcription (STAT)-4 is linked to its immunomodulatory effects. Previous studies suggest a type I IFN de... Read More about Decreased interferon-? induced STAT-4 activation in immune cells and clinical outcome in multiple sclerosis.